CCDC132 Antibodies

Santa Cruz Biotechnology delivers a wide array of CCDC132 monoclonal antibodies for investigating CCDC132 protein function. CCDC132 Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CCDC132, or Coiled-Coil Domain Containing 132, plays essential roles in cellular processes such as cell division and cytoskeletal organization. CCDC132 maintains cellular integrity and facilitates communication between cells. Research has shown that CCDC132 dysregulation is linked to various diseases, highlighting its significance as a research focus. Understanding CCDC132's molecular mechanisms and cellular functions can provide critical insights into disease development and progression. Investigating CCDC132's interaction networks and regulatory pathways may reveal new therapeutic approaches. Current research explores CCDC132's potential as a diagnostic marker and therapeutic target. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of CCDC132's role in human health and disease.